TNFRSF8 and lymphoma: To sum up, the CD30-specific aptamer functions as an excellent guiding tool to efficiently deliver anticancer agents or immune cells to target cells or to specifically trigger an intracellular signaling pathway by binding to its receptors on lymphoma cells.